Header Logo

Connection

Michael Chez to Child, Preschool

This is a "connection" page, showing publications Michael Chez has written about Child, Preschool.
Connection Strength

0.928
  1. Safety and Observations from a Placebo-Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism. Stem Cells Transl Med. 2018 04; 7(4):333-341.
    View in: PubMed
    Score: 0.139
  2. Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment. Paediatr Drugs. 2009; 11(6):397-406.
    View in: PubMed
    Score: 0.074
  3. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol. 2007 Jun; 36(6):361-5.
    View in: PubMed
    Score: 0.066
  4. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol. 2007 May; 22(5):574-9.
    View in: PubMed
    Score: 0.066
  5. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav. 2006 Feb; 8(1):267-71.
    View in: PubMed
    Score: 0.060
  6. Immunizations, immunology, and autism. Semin Pediatr Neurol. 2004 Sep; 11(3):214-7.
    View in: PubMed
    Score: 0.055
  7. Neurologic treatment strategies in autism: an overview of medical intervention strategies. Semin Pediatr Neurol. 2004 Sep; 11(3):229-35.
    View in: PubMed
    Score: 0.055
  8. Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns. Epilepsy Behav. 2004 Apr; 5(2):159-62.
    View in: PubMed
    Score: 0.053
  9. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol. 2004 Mar; 19(3):165-9.
    View in: PubMed
    Score: 0.053
  10. Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program. Epilepsia. 2023 08; 64(8):e156-e163.
    View in: PubMed
    Score: 0.050
  11. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion. Seizure. 2023 Aug; 110:42-57.
    View in: PubMed
    Score: 0.050
  12. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol. 2002 Nov; 17(11):833-7.
    View in: PubMed
    Score: 0.048
  13. Secretin and autism: a two-part clinical investigation. J Autism Dev Disord. 2000 Apr; 30(2):87-94.
    View in: PubMed
    Score: 0.040
  14. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. Nat Commun. 2019 07 12; 10(1):3094.
    View in: PubMed
    Score: 0.038
  15. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Res. 2019 08; 154:13-20.
    View in: PubMed
    Score: 0.038
  16. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry. 2006 Feb 15; 59(4):354-63.
    View in: PubMed
    Score: 0.015
  17. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics. 1999 Sep; 104(3 Pt 1):405-18.
    View in: PubMed
    Score: 0.010
  18. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr. 1999 May; 134(5):607-13.
    View in: PubMed
    Score: 0.009
  19. Antibodies to ACTH in opsoclonus-myoclonus. Neuropediatrics. 1993 Jun; 24(3):131-3.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.